Bio Solution Co.,Ltd. (KOSDAQ:086820)
South Korea · Delayed Price · Currency is KRW 7,100.00
+80.00 (1.14%)
At close: Jun 11, 2026
Bio Solution Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | 654.91 | 273.36 | -11,928 | -1,800 | -697.54 |
Depreciation & Amortization | 2,328 | 2,177 | 1,908 | 1,800 | 1,536 |
Loss (Gain) From Sale of Assets | 3.44 | 1.2 | -53.69 | - | - |
Asset Writedown & Restructuring Costs | 8.44 | 8.44 | - | - | - |
Loss (Gain) From Sale of Investments | - | - | - | -103.52 | -347.5 |
Loss (Gain) on Equity Investments | -4,477 | -4,448 | 7,112 | - | - |
Stock-Based Compensation | 330.87 | 248.48 | 42.15 | 29.77 | - |
Provision & Write-off of Bad Debts | -15.98 | -14.2 | -21.6 | -6.99 | -41.85 |
Other Operating Activities | 1,059 | 1,159 | 2,448 | 404.27 | 206.46 |
Change in Accounts Receivable | 15.52 | -181.11 | -578.12 | 696.67 | -633.85 |
Change in Inventory | -171.85 | 244.96 | -74.13 | -907.88 | 151.05 |
Change in Accounts Payable | 190.71 | -203.01 | 180.53 | 96.44 | -127.37 |
Change in Other Net Operating Assets | -1,147 | -577.43 | -1,321 | -1,896 | -2,652 |
Operating Cash Flow | -1,222 | -1,312 | -2,286 | -1,686 | -2,606 |
Capital Expenditures | -240.6 | -184.98 | -379.79 | -1,391 | -2,179 |
Sale of Property, Plant & Equipment | 180.73 | 189.23 | 172.48 | - | - |
Sale (Purchase) of Intangibles | -115.83 | -546.53 | -230.29 | -1,114 | -298.84 |
Investment in Securities | 16.6 | 1,217 | 24,693 | 6,262 | 3,453 |
Other Investing Activities | 41.12 | 62.18 | 137.59 | -0.18 | -179.02 |
Investing Cash Flow | 32.73 | 953.52 | 24,302 | 3,756 | 795.88 |
Long-Term Debt Repaid | - | -926.93 | -14,851 | -792.65 | -667.56 |
Net Debt Issued (Repaid) | -934.8 | -926.93 | -14,851 | -792.65 | -667.56 |
Issuance of Common Stock | 139.99 | 339.99 | - | 508.5 | 1,211 |
Other Financing Activities | -69.52 | -61.42 | 100 | 112.14 | -1.2 |
Financing Cash Flow | -864.33 | -648.36 | -14,751 | -172.02 | 541.74 |
Foreign Exchange Rate Adjustments | 134.72 | -32.38 | 171.48 | -15.13 | 4.03 |
Miscellaneous Cash Flow Adjustments | -0 | - | - | 0 | - |
Net Cash Flow | -1,919 | -1,039 | 7,436 | 1,883 | -1,264 |
Free Cash Flow | -1,462 | -1,497 | -2,666 | -3,077 | -4,785 |
Free Cash Flow Margin | -9.24% | -9.85% | -20.69% | -39.73% | -53.87% |
Free Cash Flow Per Share | -60.32 | -61.96 | -110.86 | -128.79 | -202.87 |
Cash Interest Paid | 97.79 | 118.37 | 126.42 | 37.51 | 50.16 |
Cash Income Tax Paid | - | -188 | -290.2 | 120.85 | 112.78 |
Levered Free Cash Flow | - | -3,003 | - | -3,942 | - |
Unlevered Free Cash Flow | - | -1,244 | - | -3,917 | - |
Change in Working Capital | -1,113 | -716.6 | -1,793 | -2,011 | -3,262 |